The impact of tangeretin combined with whey protein on exercise-induced bronchoconstriction in professional athletes: a placebo-controlled trial.
Humans
Male
Female
Double-Blind Method
Whey Proteins
/ administration & dosage
Dietary Supplements
Young Adult
Immunoglobulin E
/ blood
Athletes
Adult
Forced Expiratory Volume
Uteroglobin
/ blood
Asthma, Exercise-Induced
/ drug therapy
Exercise Test
Bronchoconstriction
/ drug effects
Sports Nutritional Physiological Phenomena
Flavones
Tangeretin
VO2max
airway inflammation
exercise-induced bronchoconstriction
lung function
respiratory symptom
Journal
Journal of the International Society of Sports Nutrition
ISSN: 1550-2783
Titre abrégé: J Int Soc Sports Nutr
Pays: United States
ID NLM: 101234168
Informations de publication
Date de publication:
Dec 2024
Dec 2024
Historique:
medline:
18
10
2024
pubmed:
18
10
2024
entrez:
18
10
2024
Statut:
ppublish
Résumé
Exercise-induced bronchoconstriction (EIB) is highly prevalent in athletes. The objective of this study was to assess the therapeutic efficacy of daily tangeretin combined with whey protein supplementation over a period of 4 weeks in professional athletes with EIB. Using a placebo-controlled, double-blind, paired, randomized trial design, a cohort of 30 professional athletes with EIB, consisting of 14 females and 16 males, was divided into two groups: the tangeretin combined with whey protein intervention group (TIG), and the placebo control group (PCG). Both the TIG and PCG underwent exercise challenge tests (ECT) and VO Tangeretin combined with whey protein use for 4 weeks attenuated the decrease in forced expiratory volume in 1 s (FEV After high-intensity exercise, athletes with EIB achieved significant improvements in lung function and blood inflammatory factors by combining tangeretin and whey protein supplementation. EIB athletes also showed longer exercise endurance and VO
Sections du résumé
BACKGROUND
UNASSIGNED
Exercise-induced bronchoconstriction (EIB) is highly prevalent in athletes. The objective of this study was to assess the therapeutic efficacy of daily tangeretin combined with whey protein supplementation over a period of 4 weeks in professional athletes with EIB.
METHODS
UNASSIGNED
Using a placebo-controlled, double-blind, paired, randomized trial design, a cohort of 30 professional athletes with EIB, consisting of 14 females and 16 males, was divided into two groups: the tangeretin combined with whey protein intervention group (TIG), and the placebo control group (PCG). Both the TIG and PCG underwent exercise challenge tests (ECT) and VO
RESULTS
UNASSIGNED
Tangeretin combined with whey protein use for 4 weeks attenuated the decrease in forced expiratory volume in 1 s (FEV
CONCLUSION
UNASSIGNED
After high-intensity exercise, athletes with EIB achieved significant improvements in lung function and blood inflammatory factors by combining tangeretin and whey protein supplementation. EIB athletes also showed longer exercise endurance and VO
Identifiants
pubmed: 39422600
doi: 10.1080/15502783.2024.2414870
doi:
Substances chimiques
Whey Proteins
0
tangeretin
I4TLA1DLX6
Immunoglobulin E
37341-29-0
Uteroglobin
9060-09-7
SCGB1A1 protein, human
0
Flavones
0
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM